IL-1-beta and TNF-alpha significantly reduced in the DMD patients six months after the addition of flavocoxid to steroid therapy, with a return to baseline values at T12; the patients treated with flavocoxid alone did not show any changes. This evidence concerns the gene TNF and Duchenne muscular dystrophy.